Status:

COMPLETED

Prognostic Factors for All Types of Cancer Combined

Lead Sponsor:

Atrium Medical Center

Collaborating Sponsors:

Maastricht University Medical Center

Conditions:

Cancer

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to investigate every possible applicability of flow cytometrical analysis in the intracellular detection of tumor-related material in activated macrophages in the broadest...

Eligibility Criteria

Inclusion

  • (Suspicion of) presence of cancer in the broadest sense of the word
  • Must be able to understand and sign written informed consent

Exclusion

  • None

Key Trial Info

Start Date :

November 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

520 Patients enrolled

Trial Details

Trial ID

NCT00704587

Start Date

November 1 2006

End Date

July 1 2015

Last Update

April 6 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Atrium Medical Centre Parkstad

Heerlen, Limburg, Netherlands, 6401 PC

2

Maastricht University Medical Centre

Maastricht, Limburg, Netherlands, 6202 AZ